World's Best Scientists 2026 revealed!
Eric Bruckert

Eric Bruckert

D-Index & Metrics

Medicine

D-Index
88
Citations
47437
World Ranking
12908
National Ranking
403

Overview

Eric Bruckert is affiliated with Sorbonne University in France and has a significant body of work in the field of medicine, with a total of 183 publications. Their research spans several subfields including surgery, endocrinology, diabetes and metabolism, economics and econometrics, cancer research, and cardiology and cardiovascular medicine.

The primary topics covered in their research include:

  • Lipoproteins and Cardiovascular Health
  • Cancer, Lipids, and Metabolism
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Systems, Economic Evaluations, Quality of Life
  • Lipid metabolism and disorders
  • Pharmaceutical Economics and Policy
  • Atherosclerosis and Cardiovascular Diseases

Eric Bruckert's recent papers demonstrate engagement with cardiovascular disease, lipid metabolism, and treatment strategies. Notable publications include:

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel, 2020, European Heart Journal
  • Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), 2021, The Lancet
  • 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance, 2023, European Heart Journal
  • Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM, 2020, Atherosclerosis
  • Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial, 2021, The Lancet Diabetes & Endocrinology

Frequent co-authors in Eric Bruckert's publications include:

  • Antonio Gallo
  • Sophie Béliard
  • Michel Farnier
  • Alain Carrié
  • Franck Boccara

The most common publication venues for Eric Bruckert are:

  • Atherosclerosis (16 publications)
  • European Heart Journal (7 publications)
  • Journal of the American College of Cardiology (5 publications)
  • Journal of clinical lipidology (4 publications)
  • Stroke (4 publications)

Best Publications

  • Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.

    Marianne Abifadel;Mathilde Varret;Jean-Pierre Rabès;Delphine Allard

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray

  • Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

    Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg

  • Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

    Vlad Ratziu;Frédéric Charlotte;Agnès Heurtier;Sophie Gombert

  • Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

    Jean-Philippe Bastard;Claude Jardel;Eric Bruckert;Patricia Blondy

  • Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard

  • Liver fibrosis in overweight patients.

    Vlad Ratziu;Philippe Giral;Frederic Charlotte;Eric Bruckert

  • Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  • Familial Hypercholesterolaemia in Children and Adolescents: Gaining Decades of Life by Optimizing Detection and Treatment

    Albert Wiegman;Samuel S. Gidding;Gerald F Watts;M John Chapman

  • Fasting is not routinely required for determination of a lipid profile: Clinical and laboratory implications including flagging at desirable concentration cut-points - A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

    Børge G. Nordestgaard;Anne Langsted;Samia Mora;Genovefa Kolovou

  • Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

    Vlad Ratziu;Philippe Giral;Sophie Jacqueminet;Fréderic Charlotte

  • Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance : The GAUSS-2 Randomized, Placebo-Controlled Phase 3 Clinical Trial of Evolocumab

    Erik Stroes;David Colquhoun;David Sullivan;Fernando Civeira

  • The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

    Robert A. Hegele;Henry N. Ginsberg;M. John Chapman;Børge G. Nordestgaard

  • Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

    Gerald F. Watts;Samuel Gidding;Anthony S. Wierzbicki;Peter P. Toth

  • Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.

    Claude Gagné;Daniel Gaudet;Eric Bruckert

  • Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

    Patrick M. Moriarty;Paul D. Thompson;Christopher P. Cannon;John R. Guyton

  • Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.

    Boris Hansel;Philippe Giral;Estelle Nobecourt;Sandrine Chantepie

  • Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial

    Steven E. Nissen;Erik Stroes;Ricardo E. Dent-Acosta;Robert S. Rosenson

  • A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke

    Amarenco P;Kim Js;Labreuche J;Charles H

Frequent Co-Authors

Pierre Amarenco
Pierre Amarenco Université Paris Cité
Gerald F. Watts
Gerald F. Watts University of Western Australia
Maciej Banach
Maciej Banach John Paul II Catholic University of Lublin
Kausik K. Ray
Kausik K. Ray Imperial College London
Børge G. Nordestgaard
Børge G. Nordestgaard University of Copenhagen
Erik S.G. Stroes
Erik S.G. Stroes University of Amsterdam
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
Daniel Gaudet
Daniel Gaudet University of Montreal
Peter P. Toth
Peter P. Toth Johns Hopkins University
Jean Ferrières
Jean Ferrières Federal University of Toulouse Midi-Pyrénées

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to a variety of rewarding healthcare careers, many of which can be accessed through flexible online programs. For those seeking advanced practice roles or specialties, pathways such as the 1 year dnp program online allow for rapid completion of Doctor of Nursing Practice (DNP) degrees. These programs are ideal for nurses aiming to move into leadership or clinical expert roles quickly.

Affordability is a major concern for many students. Prospective DNP candidates can benefit from researching the cheapest dnp programs to minimize student debt while achieving their career goals. Similarly, those interested in starting a medical career faster may consider online vocational pathways such as a fast track medical lpn program, which allows entry into nursing within a short period.

Mental health is another rapidly growing field. The online pmhnp programs offer quick routes to becoming a psychiatric mental health nurse practitioner, addressing critical gaps in mental health care. These diverse online paths make healthcare education far more accessible and convenient for students nationwide.

Best Scientists Citing Eric Bruckert

Trending Scientists